Novel BTK, PI3K Inhibitors on Horizon for Rela... - CLL Support

CLL Support

23,141 members • 39,748 posts

Novel BTK, PI3K Inhibitors on Horizon for Relapsed CLL

9 years ago•4 Replies

You need to be a member of this community to see this post.

4 Replies

You need to be a member of this community to see hidden responses.

Not what you're looking for?

You may also like...

BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'

In just a short time, in many places, BTK inhibitors (BTKi) have largely replaced...

CLLerinOzAdministrator•3 years ago

The Use of Novel PI3K Inhibitors in CLL - Dr Jennifer Brown MD Dana-Farber Cancer Institute

The Use of Novel PI3K Inhibitors in CLL...

lankisterguyVolunteer•6 years ago

BTK Inhibitor Therapy for CLL: An International Perspective - Stephan Stilgenbauer, MD

BTK Inhibitor Therapy for CLL: An International Perspective Stephan Stilgenbauer, MD Expert...

lankisterguyVolunteer•2 years ago

YABTKi or Yet Another BTK inhibitor - the A to Z list of Bruton's Tyrosine Kinase Inhibitors for CLL following Ibrutinib's success

I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...

AussieNeilPartner•5 years ago

PI3K inhibitors (idelalisib,copanlisib, duvelisib, parsaclisib, umbralisib, zandelisib, ACP-319) in CLL: where do we go from here?

While we have never been as spoiled for treatment choice as we are now, PI3K inhibitor safety is...

CLLerinOzAdministrator•2 years ago